The renin angiotensin system as a risk factor for coronary artery disease.

被引:31
作者
Farmer J.A. [1 ]
Torre-Amione G. [1 ]
机构
[1] Section of Cardiology, Ben Taub General Hospital and Baylor College of Medicine, Houston, 77030, TX
关键词
Angiotensin; Endothelial Dysfunction; Endothelial Function; Losartan; Valsartan;
D O I
10.1007/s11883-001-0047-2
中图分类号
学科分类号
摘要
The renin angiotensin system was demonstrated to play a significant role in the genesis of hypertension and regulation of vascular tone over 100 years ago. The early investigations were subsequently expanded to implicate the renin angiotensin system in a variety of physiologic processes that may play a significant role in the initiation and progression of atherosclerosis. The renin angiotensin system modulates vascular structure and left ventricular hypertrophy via a number of trophic effects. Elevated levels of angiotensin II are associated with the generation of oxidative stress, and may thus play a significant role in the earliest phases of atherosclerosis. The role inflammation plays in atherosclerosis is amplified by the renin angiotensin system via the effects on adhesion molecules, growth factors, and chemoattractant molecules, which modulate the migration of inflammatory cells into the subendothelial space. The effects of angiotensin II, which may be at least partially genetically mediated, have been implicated in epidemiologic and clinical studies as a risk factor for the development of atherosclerosis. This review centers on the potential role that the renin angiotensin system plays as a risk factor for the development of atherosclerosis, and the role of converting enzyme inhibition or angiotensin receptor blockade as a mechanism to decrease the initiation, progression, and clinical consequences of the atherosclerotic process.
引用
收藏
页码:117 / 124
页数:7
相关论文
共 108 条
[1]  
Tigerstedt R(1898)Nere-Und Kreisluaf Skandinavisches Archiv fur Phyisologie 8 223-271
[2]  
Bergman PG(1990)An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels J Clin Invest 86 1343-1343
[3]  
Rigat B(2000)Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition Circulation 102 35-41
[4]  
Hubert C(2000)Comparative study of ACE inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease J Am Coll Cardiol 35 60-66
[5]  
Alhenc-Geals F(2000)The insertion/deletion polymorphism of the angiotensin converting enzyme gene determines coronary vascular tone in nitric oxide activity J Am Coll Cardiol 36 1597-1986
[6]  
Prasad A(2000)ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension Am Heart J 140 760-765
[7]  
Narayanan S(1999)Hypertensive left ventricular remodeling and ACE gene polymorphism Cardiovasc Res 43 192-199
[8]  
Husain S(1999)Angiotensin II type 1 receptor gene polymorphism in long-term survival in patients with idiopathic congestive heart failure Eur J Heart Fail 1 363-369
[9]  
Anderson TJ(2000)Large-scale test of hypothesised associations between the angiotensin converting enzyme insertion/deletion polymorphism and myocardial infarction in about 5,000 cases and 6,000 controls. International Studies of Infarct Survival (ISIS) collaborators Lancet 355 434-442
[10]  
Elstein E(1999)Angiotensin converting enzyme and cardiovascular disease risk Curr Opin Lipidol 10 407-415